483
Xtreem Pulse LLCFDA 483 - Xtreem Pulse LLC - June 29, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Xtreem Pulse LLC, a specification developer in New York, revealed significant deficiencies in their quality system. The firm failed to establish adequate procedures for design changes, purchasing controls, and overall design control for their PureLift Face and PureLift Pro facial stimulation devices. These issues indicate a lack of documented processes for critical aspects of medical device development and manufacturing.
Open in Dashboard
ID · 92d69a2d-bf6a-4d91-abd9-7ab8c39e3ea2